INVO Fertility (IVF) Income from Continuing Operations (2011 - 2025)
INVO Fertility (IVF) reported Income from Continuing Operations of 2644625.0 for Q3 2025, down 62.18% year-over-year from 6992859.55 in Q3 2024, and up 17.59% sequentially from 3209094.0 in Q2 2025.
INVO Fertility (IVF) Income from Continuing Operations (2011 - 2025) Analysis & Trends
INVO Fertility has disclosed Income from Continuing Operations across 15 years of filings, most recently posting 2644625.0 for Q3 2025.
- Quarterly Income from Continuing Operations fell 62.18% year-over-year to 2644625.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 26876298.0 (down 259.93% YoY) and the FY2024 annual result came in at 9095838.0, down 13.21% from the prior year.
- Income from Continuing Operations improved to 2644625.0 in Q3 2025, from 3209094.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 101782.0 in Q4 2021 and bottomed at 17399086.0 in Q1 2025.
- The 5-year median for Income from Continuing Operations is 2481326.0 (2021), against an average of 3044920.26.
- Year-over-year, Income from Continuing Operations soared 102.67% in 2021 and sank 2818.28% in 2022.
- INVO Fertility's Income from Continuing Operations stood at 101782.0 in 2021, then sank by 2818.28% to 2766721.0 in 2022, then rose by 27.9% to 1994782.0 in 2023, then plunged by 81.65% to 3623493.0 in 2024, then rose by 27.01% to 2644625.0 in 2025.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 2644625.0, 3209094.0, and 17399086.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | INVO Fertility | 5.31 Mn | 4.91 Mn | 629,345.00 | -2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.64 Mn |
| Jun 30, 2025 | -3.21 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -3.62 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | -1.99 Mn |
| Sep 30, 2023 | -1.25 Mn |
| Jun 30, 2023 | -2.24 Mn |
| Mar 31, 2023 | -2.55 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -2.55 Mn |
| Jun 30, 2022 | -2.80 Mn |
| Mar 31, 2022 | -2.70 Mn |
| Dec 31, 2021 | 101,782.00 |
| Sep 30, 2021 | -2.48 Mn |
| Jun 30, 2021 | -1.82 Mn |
| Mar 31, 2021 | -2.45 Mn |
| Dec 31, 2020 | -3.81 Mn |